Table 1. Detection rate of CTC in metastatic colorectal cancer: comparison between CellSearch and Adnatest.
CTC AdnaTest | Total | ||
---|---|---|---|
Negative | Positive | ||
CTC Veridex 0 count | 5 | 26 | 31 |
% within CTC Veridex | 16.1% | 83.9% | 100.0% |
% within CTC AdnaTest | 71.4% | 81.2% | 79.5% |
% of total | 12.8% | 66.7% | 79.5% |
CTC Veridex 1 count | 1 | 2 | 3 |
% within CTC Veridex | 33.3% | 66.7% | 100.0% |
% within CTC AdnaTest | 14.3% | 6.2% | 7.7% |
% of total | 2.6% | 5.1% | 7.7% |
CTC Veridex 2 count | 1 | 0 | 1 |
% within CTC Veridex | 100.0% | 0.0% | 100.0% |
% within CTC AdnaTest | 14.3% | 0.0% | 2.6% |
% of total | 2.6% | 0.0% | 2.6% |
CTC Veridex 3 count | 0 | 1 | 1 |
% within CTC Veridex | 0.0% | 100.0% | 100.0% |
% within CTC AdnaTest | 0.0% | 3.1% | 2.6% |
% of total | 0.0% | 2.6% | 2.6% |
CTC Veridex 5 count | 0 | 2 | 2 |
% within CTC Veridex | 0.0% | 100.0% | 100.0% |
% within CTC AdnaTest | 0.0% | 6.2% | 5.1% |
% of total | 0.0% | 5.1% | 5.1% |
CTC Veridex 11 count | 0 | 1 | 1 |
% within CTC Veridex | 0.0% | 100.0% | 100.0% |
% within CTC AdnaTest | 0.0% | 3.1% | 2.6% |
% of total | 0.0% | 2.6% | 2.6% |
Total count | 7 | 32 | 39 |
% within CTC Veridex | 17.9% | 82.1% | 100.0% |
% within CTC AdnaTest | 100.0% | 100.0% | 100.0% |
% of total | 17.9% | 82.1% | 100.0% |